<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="42187">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02557152</url>
  </required_header>
  <id_info>
    <org_study_id>CS-10</org_study_id>
    <nct_id>NCT02557152</nct_id>
  </id_info>
  <brief_title>The GentleWave Registry</brief_title>
  <official_title>The GentleWave Post-Market Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sonendo, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sonendo, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this registry is to gain a real world perspective for the use and outcomes
      associated with the Sonendo® GentleWave System usage. The registry population includes up to
      500 subjects that have been treated with the Sonendo GentleWave System at up to 25 clinical
      sites in the United States.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this registry is to gain a real world perspective for the use and outcomes
      associated with the Sonendo® GentleWave System usage.

      Up to 25 clinical sites in the United States. Up to 500 subjects that have been treated with
      the Sonendo GentleWave System. To assess outcomes for teeth treated with the GentleWave
      System in a commercial setting.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
  </study_design_info>
  <target_duration>24 Months</target_duration>
  <primary_outcome>
    <measure>Healing</measure>
    <time_frame>24 months</time_frame>
    <description>Radiographic analysis and clinical signs and symptoms at 24 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Retreatment Rates</measure>
    <time_frame>24 months</time_frame>
    <description>Rate of retreatment at 24 months</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Root Canal</condition>
  <arm_group>
    <arm_group_label>Patients that were treated with the GentleWave System</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GentleWave System Treatment</intervention_name>
    <arm_group_label>Patients that were treated with the GentleWave System</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Up to 500 subjects that have been treated with the Sonendo GentleWave System.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  One or more teeth treated with the Sonendo GentleWave System

        Exclusion Criteria:

          -  Institutionalized patients or prisoners
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sara Rodriguez</last_name>
    <role>Study Director</role>
    <affiliation>Sonendo, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brandy Snowden</last_name>
    <email>bsnowden@sonendo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Randy Garland, DDS</name>
      <address>
        <city>Encinitas</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brandy Snowden</last_name>
      <email>bsnowden@sonendo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stacey Woo, DDS</name>
      <address>
        <city>Whittier</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brandy Snowden</last_name>
      <email>bsnowden@sonendo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 17, 2016</lastchanged_date>
  <firstreceived_date>September 21, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
